Terms: = Liver cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
28 results:
1. Prognostic Impact of a Novel Albumin-Platelet Index as Selection Criterion for Hepatic Resection in Intermediate Stage Hepatocellular Carcinoma.
Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
Anticancer Res; 2023 Apr; 43(4):1835-1842. PubMed ID: 36974828
[TBL] [Abstract] [Full Text] [Related]
2. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification.
Yamamoto M; Kobayashi T; Hashimoto M; Kuroda S; Kawaoka T; Aikata H; Chayama K; Ohdan H
BMC Cancer; 2021 Jun; 21(1):668. PubMed ID: 34090354
[TBL] [Abstract] [Full Text] [Related]
3. BCLC-B Subclassification and the Hong Kong liver cancer System in Intermediate Hepatocellular Carcinoma: Identifying Candidates for Curative Therapy.
Longo L; Rodrigues de Freitas LB; Santos D; Grivicich I; Álvares-da-Silva MR
Am J Clin Oncol; 2019 May; 42(5):466-471. PubMed ID: 30913090
[TBL] [Abstract] [Full Text] [Related]
4. Using Lamin B1 mRNA for the early diagnosis of hepatocellular carcinoma: a cross-sectional diagnostic accuracy study.
Abdelghany AM; Rezk NS; Osman MM; Hamid AI; Al-Breedy AM; Abdelsattar HA
F1000Res; 2018; 7():1339. PubMed ID: 30467522
[No Abstract] [Full Text] [Related]
5. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma.
Wei WX; Yang ZS; Lu LH; Li J; Lei ZQ; Wang K; Xia Y; Yan ZL; Shen F
Int J Surg; 2018 Aug; 56():256-263. PubMed ID: 29935368
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
Tian Y; Lyu H; He Y; Kanduri HK
J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Biolato M; Gallusi G; Iavarone M; Cabibbo G; Racco S; De Santis A; Corte CD; Maida M; Attili AF; Sangiovanni A; Cammà C; La Torre G; Gasbarrini A; Grieco A
Ann Hepatol; 2018; 17(1):110-118. PubMed ID: 29311396
[TBL] [Abstract] [Full Text] [Related]
8. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
[TBL] [Abstract] [Full Text] [Related]
9. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract] [Full Text] [Related]
10. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma.
Llovet JM; Zucman-Rossi J; Pikarsky E; Sangro B; Schwartz M; Sherman M; Gores G
Nat Rev Dis Primers; 2016 Apr; 2():16018. PubMed ID: 27158749
[TBL] [Abstract] [Full Text] [Related]
12. Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Farinati F; Vitale A; Spolverato G; Pawlik TM; Huo TL; Lee YH; Frigo AC; Giacomin A; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Biasini E; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Masotto A; Trevisani F; Cillo U;
PLoS Med; 2016 Apr; 13(4):e1002006. PubMed ID: 27116206
[TBL] [Abstract] [Full Text] [Related]
13. Image-based Multilevel Subdivision of M1 Category in TNM staging System for Metastatic Nasopharyngeal Carcinoma.
Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
[TBL] [Abstract] [Full Text] [Related]
14. Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria).
Kudo M; Arizumi T; Ueshima K; Sakurai T; Kitano M; Nishida N
Dig Dis; 2015 Oct; 33(6):751-8. PubMed ID: 26488473
[TBL] [Abstract] [Full Text] [Related]
15. Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients.
Weinmann A; Koch S; Sprinzl M; Kloeckner R; Schulze-Bergkamen H; Düber C; Lang H; Otto G; Wörns MA; Galle PR
Liver Int; 2015 Feb; 35(2):591-600. PubMed ID: 25290314
[TBL] [Abstract] [Full Text] [Related]
16. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.
Bolondi L; Burroughs A; Dufour JF; Galle PR; Mazzaferro V; Piscaglia F; Raoul JL; Sangro B
Semin Liver Dis; 2012 Nov; 32(4):348-59. PubMed ID: 23397536
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic role of CD10⁺ myeloid cells in association with tumor budding at the invasion front of colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Sugihara H; Shimizu T; Shiomi H; Murata S; Naka S; Yamamoto H; Endo Y; Tani T
Cancer Sci; 2011 Sep; 102(9):1724-33. PubMed ID: 21599811
[TBL] [Abstract] [Full Text] [Related]
18. [A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
Kim HM; Ikeda M; Okano M; Miyoshi N; Hirose H; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2548-50. PubMed ID: 21224635
[TBL] [Abstract] [Full Text] [Related]
19. Primary hepatic low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type: a case report and review of the literature.
Murakami J; Fukushima N; Ueno H; Saito T; Watanabe T; Tanosaki R; Kobayashi Y; Matsuno Y; Tobinai K
Int J Hematol; 2002 Jan; 75(1):85-90. PubMed ID: 11843297
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases.
Weber JC; Schneider A; Rohr S; Nakano H; Bachellier P; Méchine A; Hamel G; Kanor M; Chenard MP; Gaub MP; Oudet P; Meyer C; Jaeck D
Ann Surg; 2001 Dec; 234(6):795-802; discussion 802-3. PubMed ID: 11729386
[TBL] [Abstract] [Full Text] [Related]
[Next]
